Results 221 to 230 of about 63,908 (269)

Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells [PDF]

, 2006
Frank de Wolf, Cornelia Wandke, Nina Isenberg, Stephan Geley   +3 more
openalex   +1 more source

Cdc14B/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma. [PDF]

Am J Cancer Res
Wang T, Wang S, Wang T, Jia L, Nan G, Wang L.   +5 more
europepmc   +1 more source

Effects of Artificial Stimulations on the activation of oocyte and the expression of cyclin B1 protein in mouse oocytes [PDF]

, 2006
Stephen S. Hwang, C. K. Kim, Young Chul Chung   +2 more
openalex   +1 more source

Multisite Phosphorylation of Nuclear Interaction Partner of ALK (NIPA) at G2/M Involves Cyclin B1/Cdk1 [PDF]

, 2007
Florian Bassermann, Christine von Klitzing, Anna Lena Illert, Silvia Münch, Stephan W. Morris, Michele Pagano, Christian Peschel, Justus Duyster   +7 more
openalex   +1 more source

Dietary flavonoid tectochrysin synergistically enhances cisplatin sensitivity on ovarian cancer cells through targeting the CDK1/cyclin B1 pathway

Journal of Functional Foods
This study investigates the effect of tectochrysin, a flavonoid found in plants and fruits in ovarian cancer. We employed in vitro assays to assess the impact of tectochrysin in ovarian cancer cells.
Shasha Liu, Yuling Guo, Feiya Jiang, Caiyan Liu, Wenwen Zhang, Hui Zhao, Pengpeng Qu   +6 more
doaj  

Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase [PDF]

, 2014
Cascales, H.S., Jaiswal, H., Lindqvist, A., Müllers, E., Saurin, A.T.   +4 more
core   +3 more sources

The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway. [PDF]

Int J Biol Sci
Wang F, Fu X, Chang M, Wei T, Lin R, Tong H, Zhang X, Yuan R, Zhou Z, Huang X, Zhang W, Su W, Lu Y, Liang Z, Zhang J.   +14 more
europepmc   +1 more source

YTHDF1 Promotes Cyclin B1 Translation through m⁶A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. [PDF]

Cells, 2021
Lou X, Ning J, Liu W, Li K, Qian B, Xu D, Wu Y, Zhang D, Cui W.   +8 more
europepmc   +1 more source

Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer. [PDF]

J Gynecol Oncol
Parulekar M, Kim H, Kim K, Ala A.
europepmc   +1 more source

Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage. [PDF]

Int J Mol Sci, 2021
Ikeda Y, Yasutake R, Yuki R, Saito Y, Nakayama Y.   +4 more
europepmc   +1 more source